Ignite Creation Date:
2025-12-26 @ 2:39 PM
Ignite Modification Date:
2025-12-30 @ 1:57 PM
Study NCT ID:
NCT01416506
Status:
COMPLETED
Last Update Posted:
2013-11-05
First Post:
2011-08-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Community-Acquired Pneumonia (CAP) Surveillance
Sponsor:
Bayer
Organization:
Study Overview
Official Title:
Community-Acquired Pneumonia (CAP) Mycoplasma Surveillance
Status:
COMPLETED
Status Verified Date:
2013-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Prospective, non-interventional, multi-center study. 7 investigative centers will involved in China. Around 560 CAP outpatients or inpatients will be screened until 56 M. pneumoniae isolates collected.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| NN1010CN | OTHER | Company Internal | View |